Industry

The long-standing partnership between AIBN and Clarity Pharmaceuticals continues to thrive with the signing of a brand-new Supply Agreement for radionuclide, Copper-64.

A new parcel of federal funding will help AIBN researchers produce clinical-grade mRNA products that are safer and better quality, and will potentially cost less.

Queensland researchers and farmers are teaming up to design nanotechnology that repurposes agricultural waste into high-value soil products.

When it comes to precision medicine, advanced biomanufacturing and nanoengineered materials, if you dream it, the AIBN can do it.

Two exciting AIBN projects have scored new funding to help industry collaborators crack the lucrative computer chip industry and capitalise on opportunities in waste-to-catalyst conversion

Four AIBN-led projects have been recognised in latest round of the $220 million Australian Research Council Discovery scheme, a program that recognises research with economic, commercial, environmental, social and/or cultural benefits.

New AIBN battery technology to help meet the global electrification demand has taken another step towards commercialisation.

AIBN researchers are using the latest sequencing technology developed by UK-based biotech Oxford Nanopore Technologies to analyse mRNA vaccines and therapies.

The AIBN's Centre for Advanced Imaging (CAI) has launch an Australian-first facility that will use radiometals for cancer therapy.

Two rising research stars have shown just why the AIBN is renowned as an incubator for scientific talent, each securing $440,000 funding to accelerate their game-changing work.